Using microarrays to predict resistance to chemotherapy in cancer patients.
about
MIMAS: an innovative tool for network-based high density oligonucleotide microarray data management and annotationModulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy.Gene Expression Profiles – What the Clinician Needs to Know.
P2860
Using microarrays to predict resistance to chemotherapy in cancer patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Using microarrays to predict resistance to chemotherapy in cancer patients.
@ast
Using microarrays to predict resistance to chemotherapy in cancer patients.
@en
type
label
Using microarrays to predict resistance to chemotherapy in cancer patients.
@ast
Using microarrays to predict resistance to chemotherapy in cancer patients.
@en
prefLabel
Using microarrays to predict resistance to chemotherapy in cancer patients.
@ast
Using microarrays to predict resistance to chemotherapy in cancer patients.
@en
P2860
P356
P1433
P1476
Using microarrays to predict resistance to chemotherapy in cancer patients.
@en
P2093
Chung-Hae Lee
Pascale F Macgregor
P2860
P304
P356
10.1517/14622416.5.6.611
P577
2004-09-01T00:00:00Z